The efficacy and tolerability issue of generics of imatinib in the treatment of chronic myeloid leukemia: do generics really jeopardize patient safety?

Date
2015
Author
Soysal, Teoman
Eskazan, AHMET EMRE
Ar, Muhlis Cem
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/141538
https://doi.org/10.3109/10428194.2014.947609
Collections